• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Association Between Metabolically Healthy Obesity and the Risk of Proteinuria: The Kansai Healthcare Study.代谢健康型肥胖与蛋白尿风险的关联:关西医疗保健研究。
J Epidemiol. 2018 Aug 5;28(8):361-366. doi: 10.2188/jea.JE20170082. Epub 2018 Apr 7.
2
Metabolically healthy obesity and risk of incident CKD.代谢健康型肥胖与慢性肾脏病发病风险
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):578-83. doi: 10.2215/CJN.08980914. Epub 2015 Jan 29.
3
Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.代谢健康表型的自然病程及发生心血管代谢疾病的风险:一项为期三年的随访研究。
BMC Endocr Disord. 2021 Apr 28;21(1):85. doi: 10.1186/s12902-021-00754-1.
4
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.从代谢健康到不健康表型的转变与 BMI 类别中 90257 名女性心血管疾病风险的关系:前瞻性队列研究 30 年随访。
Lancet Diabetes Endocrinol. 2018 Sep;6(9):714-724. doi: 10.1016/S2213-8587(18)30137-2. Epub 2018 May 31.
5
Relationship Between Alcohol Drinking Pattern and Risk of Proteinuria: The Kansai Healthcare Study.饮酒模式与蛋白尿风险之间的关系:关西医疗保健研究
J Epidemiol. 2016 Sep 5;26(9):464-70. doi: 10.2188/jea.JE20150158. Epub 2016 Feb 20.
6
Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study.代谢健康型肥胖与缺血性心脏病:Inter99研究的10年随访
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1934-1942. doi: 10.1210/jc.2016-3346.
7
The association between metabolic health, obesity phenotype and the risk of breast cancer.代谢健康、肥胖表型与乳腺癌风险之间的关联。
Int J Cancer. 2017 Jun 15;140(12):2657-2666. doi: 10.1002/ijc.30684. Epub 2017 Mar 28.
8
The risk of chronic kidney disease in a metabolically healthy obese population.代谢健康肥胖人群的慢性肾脏病风险。
Kidney Int. 2015 Oct;88(4):843-50. doi: 10.1038/ki.2015.183. Epub 2015 Jun 24.
9
Blood pressure components and the risk for proteinuria in Japanese men: The Kansai Healthcare Study.日本男性的血压成分与蛋白尿风险:关西医疗保健研究
J Epidemiol. 2017 Nov;27(11):505-510. doi: 10.1016/j.je.2016.10.010. Epub 2017 Jul 11.
10
Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study.代谢健康型肥胖与慢性肾脏病的发生发展:一项队列研究。
Ann Intern Med. 2016 Mar 1;164(5):305-12. doi: 10.7326/M15-1323. Epub 2016 Feb 9.

引用本文的文献

1
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease-2025 Update.亚太肾脏病学会糖尿病肾病临床实践指南 - 2025年更新版
Nephrology (Carlton). 2025 Jul;30 Suppl 2(Suppl 2):3-56. doi: 10.1111/nep.70030.
2
Framework of Guidelines for Management of CKD in Asia.亚洲慢性肾脏病管理指南框架
Kidney Int Rep. 2023 Dec 22;9(4):752-790. doi: 10.1016/j.ekir.2023.12.010. eCollection 2024 Apr.
3
Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.2 型糖尿病患者的代谢表型与终末期肾病风险。
Front Endocrinol (Lausanne). 2023 May 10;14:1103251. doi: 10.3389/fendo.2023.1103251. eCollection 2023.

本文引用的文献

1
Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals.脂联素水平可区分肥胖和非肥胖白人个体中的代谢健康与不健康状态。
J Clin Endocrinol Metab. 2015 Nov;100(11):4172-80. doi: 10.1210/jc.2015-2765. Epub 2015 Sep 24.
2
Metabolically healthy obesity and risk of incident CKD.代谢健康型肥胖与慢性肾脏病发病风险
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):578-83. doi: 10.2215/CJN.08980914. Epub 2015 Jan 29.
3
The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used.代谢健康型肥胖的患病率:一项系统综述及对所用定义的批判性评估。
Obes Rev. 2014 Oct;15(10):781-90. doi: 10.1111/obr.12198. Epub 2014 Jul 16.
4
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.代谢健康型肥胖与心血管疾病及2型糖尿病风险:白厅II队列研究
Eur Heart J. 2015 Mar 1;36(9):551-9. doi: 10.1093/eurheartj/ehu123. Epub 2014 Mar 26.
5
Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.代谢不健康的正常体重个体和代谢健康的肥胖个体患糖尿病和心血管疾病的风险。
J Clin Endocrinol Metab. 2014 Feb;99(2):462-8. doi: 10.1210/jc.2013-2832. Epub 2013 Nov 20.
6
Metabolically healthy obesity: definitions, determinants and clinical implications.代谢健康型肥胖:定义、决定因素及临床意义。
Rev Endocr Metab Disord. 2013 Sep;14(3):219-27. doi: 10.1007/s11154-013-9252-x.
7
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.代谢健康肥胖表型中的糖尿病和心血管疾病结局:一项队列研究。
Diabetes Care. 2013 Aug;36(8):2388-94. doi: 10.2337/dc12-1971. Epub 2013 Mar 14.
8
Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans.矛盾性高脂联素血症与非裔美国人的代谢健康肥胖(MHO)表型相关。
J Endocrinol Metab. 2012 Apr 1;2(2):51-65. doi: 10.4021/jem95W.
9
Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men.吸烟与健康中年男性肾小球高滤过和蛋白尿的关系。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2462-9. doi: 10.2215/CJN.00700111. Epub 2011 Sep 1.
10
Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes.估算肾小球滤过率、蛋白尿与不良心血管结局的相关性。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1418-26. doi: 10.2215/CJN.09741110. Epub 2011 Apr 28.

代谢健康型肥胖与蛋白尿风险的关联:关西医疗保健研究。

The Association Between Metabolically Healthy Obesity and the Risk of Proteinuria: The Kansai Healthcare Study.

机构信息

Preventive Medicine and Environmental Health, Osaka City University Graduate School of Medicine.

Hematology, Osaka City University Graduate School of Medicine.

出版信息

J Epidemiol. 2018 Aug 5;28(8):361-366. doi: 10.2188/jea.JE20170082. Epub 2018 Apr 7.

DOI:10.2188/jea.JE20170082
PMID:29628481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6048297/
Abstract

BACKGROUND

Metabolically healthy obesity seems to be a unique phenotype for the risk of cardiometabolic diseases. However, it is not known whether this phenotype is associated with the risk of proteinuria.

METHODS

Study subjects were 9,185 non-diabetic Japanese male workers aged 40-55 years who had no proteinuria, an estimated glomerular filtration rate ≥60 mL/min/1.73 m, no history of cancer, and no use of antihypertensive or lipid-lowering medications at baseline. Obesity was defined as body mass index ≥25.0 kg/m. Metabolic health was defined as the presence of no Adult Treatment Panel III components of the metabolic syndrome criteria, excluding waist circumference, and metabolic unhealth was defined as the presence of one or more metabolic syndrome components, excluding waist circumference. "Consecutive proteinuria" was considered positive if proteinuria was detected twice consecutively as 1+ or higher on urine dipstick at annual examinations to exclude chance proteinuria as much as possible.

RESULTS

During the 81,660 person-years follow-up period, we confirmed 390 cases of consecutive proteinuria. Compared with metabolically healthy non-obesity, metabolically healthy obesity was not associated with the risk of consecutive proteinuria (multiple-adjusted hazard ratio [HR] 0.86; 95% confidence interval [CI], 0.37-1.99), but metabolically unhealthy non-obesity with ≥2 metabolic syndrome components (HR 1.77; 95% CI, 1.30-2.42), metabolically unhealthy obesity with one component (HR 1.71; 95% CI, 1.12-2.61), and metabolically unhealthy obesity with ≥2 metabolic syndrome components (HR 2.77; 95% CI, 2.01-3.82) were associated with an increased risk of consecutive proteinuria.

CONCLUSIONS

Metabolically healthy obesity did not increase the risk of consecutive proteinuria in Japanese middle-aged men.

摘要

背景

代谢健康型肥胖似乎是一种独特的表型,与心血管代谢疾病的风险相关。然而,目前尚不清楚这种表型是否与蛋白尿风险相关。

方法

研究对象为 9185 名非糖尿病的日本男性工人,年龄在 40-55 岁之间,基线时无蛋白尿、估计肾小球滤过率≥60 mL/min/1.73 m²、无癌症史且未使用降压或降脂药物。肥胖定义为体质指数≥25.0 kg/m²。代谢健康定义为不存在美国成人治疗指南 III 代谢综合征标准的组分,不包括腰围;代谢不健康定义为存在一个或多个代谢综合征组分,不包括腰围。“连续蛋白尿”定义为在年度体检中,两次连续尿蛋白试纸检测为 1+或更高,以尽可能排除偶然蛋白尿。

结果

在 81660 人年的随访期间,我们确诊了 390 例连续蛋白尿病例。与代谢健康非肥胖相比,代谢健康型肥胖与连续蛋白尿风险无关(多因素调整后的风险比 [HR] 0.86;95%置信区间 [CI],0.37-1.99),但代谢不健康非肥胖且有≥2 个代谢综合征组分(HR 1.77;95% CI,1.30-2.42)、代谢不健康肥胖且有 1 个组分(HR 1.71;95% CI,1.12-2.61)、代谢不健康肥胖且有≥2 个代谢综合征组分(HR 2.77;95% CI,2.01-3.82)与连续蛋白尿风险增加相关。

结论

在日本中年男性中,代谢健康型肥胖不会增加连续蛋白尿的风险。